BritPACT

[PsA HQ @PsAZZGroup]

@bethangoulden On a petitioning note of my own: will @RheumatologyUK allow 'unfunded' #PatientResearchPartners access to the annual conference at the same zero rate as students? Even remote free access would enable them to participate, learn and give valuable input🖐️

[Hippocrates-IMI @Hippocrates_IMI]

We're making great progress in our recruitment for the #HPOS study, focusing on #psoriasis. Recruitment has just begun in Romania and Poland, while in the UK, Ireland, Portugal and Greece, we've already enrolled 3680 patients!

Visit https://t.co/JyTMSRneEN for more information!

[PsA HQ @PsAZZGroup]

Sharing a research survey for UK rheumatology Patient Research Partners (aka ‘Patient Experts’). This survey explores the PRP experience, gaps in mentoring, training and guidance. #BritPact2024
Please share:
https://t.co/QQ9ARiDoGo

[BritPACT @BritPact]

Congratulations to our prize winners at #BritPACT2024

[BritPACT @BritPact]

Reporting back from the axial PsA workshop on
1. Who to screen?
2. How to classify axial PsA?
3. How do we measure disease activity?

[BritPACT @BritPact]

@uk_biobank This work funded by a @BritPact research grant has led to an ACF post @ndorms and is supporting plans for a PhD fellowship application.

[BritPACT @BritPact]

Dylan McGagh presenting additional data from @uk_biobank on risk of PsA. Associations with exercise may be more important than those with prodromal symptoms.

[BritPACT @BritPact]

@OfficialUoM This initial work funded by @BritPact has now been developed into a £300k MRC study!

[BritPACT @BritPact]

Ryan Hum from @OfficialUoM presenting his work funded by a @BritPact Research Grant looking at cells within arthritic joints to understand what is causing disease.

[BritPACT @BritPact]

Preliminary data on PsARC response shows similar OR for 2nd to 7th line therapy. Further modelling underway to adjust for baseline differences. This supports further access to sequential lines of therapy.

[BritPACT @BritPact]

@DrWTillett presenting work from the SEQUENCE project, on behalf of Charlotte Gollins, investigating efficacy of sequential biologics in PsA

[BritPACT @BritPact]

Use of sequential biologics is common across the UK but 83% of centres had restrictions on biologic use and 25% had restrictions on number of drugs (2, 4 or 5 therapies per patient)

[BritPACT @BritPact]

A call for applications for the @BritPACT research grant in honour of Dr Deepak Jadon. Get preparing your applications for 24th January 2025 and more details from [email protected]

[BritPACT @BritPact]

And a thank you to all of our amazing committee members for their work and input over the last year

[BritPACT @BritPact]

Updates from our chair @njg01 Nicola Gullick on BritPACT achievements....

[BritPACT @BritPact]

@NIHRresearch More to come in the afternoon workshop thinking about BritPACT research in axial PsA....

[BritPACT @BritPact]

And now Professor Jon Packham presenting further research in axial SpA and highlighting research gaps particularly in axial PsA.

[BritPACT @BritPact]

Highlighting ongoing research in axial SpA with the @NIHRresearch funded IDEAL study.

[BritPACT @BritPact]

A digital public awareness campaign to help identify axial SpA and encourage people to approach their GP. 73% of people completed the survey in NI and met referral criteria.

[BritPACT @BritPact]

Recent data from @NASSexercise shows that the delay in diagnosis is still over 8 years with a big delay in referral from primary care to rheumatology.

[BritPACT @BritPact]

Back from lunch and kicking off an a session on axial PsA with @NASSchiefexec Dale Webb from @NASSexercise looking at axSpA diagnostic delay